Cardiovasc Diabetol
Cardiovascular Diabetology is a leading peer-reviewed, open access journal published by BioMed Central, dedicated to advancing the understanding of the intricate relationship between diabetes mellitus and cardiovascular disease. With an ISSN of 1475-2840 and a distinguished 2026 Impact Factor of 8.9490, the journal holds a Q1 ranking in its JCR quartile, reflecting its high citation impact and significant influence within the fields of cardiology, endocrinology, and metabolism. The journal’s scope encompasses all aspects of the interaction between diabetes and cardiovascular disorders, including but not limited to diabetic cardiomyopathy, atherosclerosis, hypertension, stroke, and the cardiovascular complications of insulin resistance and metabolic syndrome. It publishes a wide array of article types, including original research articles, comprehensive reviews, brief reports, and methodological papers, all of which undergo rigorous single-blind peer review to ensure scientific excellence. The target audience comprises cardiologists, endocrinologists, diabetologists, vascular biologists, clinical researchers, and public health professionals seeking timely, high-quality data on the pathophysiology, prevention, diagnosis, and treatment of cardiovascular complications in diabetic patients. A notable feature of Cardiovascular Diabetology is its open access model, which ensures that all published content is freely and permanently available online, maximizing global dissemination and visibility. As a top-tier Q1 journal with an Impact Factor well above the average in its specialty, it stands as a premier venue for groundbreaking research that bridges two critical areas of modern medicine, making it essential reading for clinicians and scientists dedicated to improving outcomes for patients with diabetes and cardiovascular comorbidities.